[1]
2025. Durable complete response in a patient with BRAF-mutated advanced melanoma with ocular and skin toxicities from BRAF/MEK targeted therapy after immune checkpoint inhibitor treatment: a case report. Dermatology Reports. (Jun. 2025). DOI:https://doi.org/10.4081/dr.2025.10324.